| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 97.0677 | 75 |
| GSM780708 | Untreated after 4 days (C2_1) | 88.3866 | 73 |
| GSM780709 | Untreated after 4 days (C3_1) | 91.6287 | 74 |
| GSM780719 | Untreated after 4 days (C1_2) | 94.0156 | 74 |
| GSM780720 | Untreated after 4 days (C2_2) | 107.048 | 76 |
| GSM780721 | Untreated after 4 days (C3_2) | 100.137 | 75 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 91.5244 | 74 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 100.476 | 75 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 77.4435 | 71 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 85.0144 | 73 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 91.9908 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 94.6958 | 74 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 87.3525 | 73 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 77.9375 | 71 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 88.4665 | 73 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 94.9103 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 89.2859 | 74 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 82.0076 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 90.8705 | 74 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 83.4759 | 72 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 103.089 | 76 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 102.618 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 104.404 | 76 |